Expert View
Refine Search
Pharmaceutical
Robert Mauch, executive vice president and group president of AmerisourceBergen, considers the evolving role of distributors in an Expert View piece. 7 November 2019
Pharmaceutical
Maurits Lugard and Anna-Shari Melin from law firm Sidley Austin provide an Expert View on the European Medicines Agency’s (EMA) recent guidance on medicinal pro 24 October 2019
Pharmaceutical
David Baker, a business consultant at J+D Forecasting, provides an Expert View on potential implications for the pharmaceutical industry of UK Labour Party lead 17 October 2019
Biotechnology
Collaboration between data scientists, technologists, clinicians and other specialists will be crucial to keeping up with growing consumer demand for microbiome 9 October 2019
Biotechnology
Karl Roberts, EY transactions advisory services managing director, shares an Expert View on individualized cell and gene therapies. 4 October 2019
Pharmaceutical
Anthony Barron, principal of the life sciences practice of Charles River Associates, considers how to better position European healthcare systems to support inn 9 August 2019
Pharmaceutical
It may sound surprising, but the most common form of poisoning in the UK is from medication according to NHS figures and children under five are most at risk. 30 July 2019
Pharmaceutical
Melonie Warfel, vice president and general manager for life sciences at software company Model N, provides an Expert View column on pharma's hottest topic. 24 July 2019
Biotechnology
Minzhang Chen, chief executive of WuXi STA, provides an Expert View on the opening up of the world's second largest pharma market. 3 July 2019
Generics
Ayesha Raghib, associate at IP law firm Powell Gilbert, provides an Expert View on the imminent introduction of legislation that could prompt a spike in pharma 27 June 2019
Biotechnology
The healthcare industry is at an inflection point with the market now preparing for more cell and gene therapies to be approved, writes Ana Stojanovska, vice pr 21 June 2019
Pharmaceutical
An Expert View on a burgeoning area that should tempt life science investors and professionals to leave their prejudice behind and take a closer look.from Jeann 15 June 2019
Pharmaceutical
Patients must always be the center around which the entire innovation process revolves, while seeking to satisfy unmet patient needs, writes Alfredo Barón de Ju 5 June 2019
Biotechnology
Strategic investments in pharmaceutical and biotech companies that focus on cost-saving breakthrough therapies may also deliver stronger returns.Investors stand 24 May 2019
Pharmaceutical
Lithuania's new assessment procedure for reimbursable medicines: will there be any positive changes?
Lithuanian attorney Ruta Pumputiene provides an Expert View on amendments to the Lithuanian Pharmaceutical Law and the subsequent changes to the reimbursable me 15 May 2019
Pharmaceutical
Edward Jones, policy and communications consultant at GK Strategy, provides an Expert View on how companies can take advantage of the UK National Health Service 10 May 2019
Pharmaceutical
In an Expert View piece, Oliver Kidd, senior associate at Stevens & Bolton, provides an overview of an ever-more complex landscape. 24 April 2019
Pharmaceutical
Professional investors are a fascinating group of individuals, enjoying an incredibly direct link between results and reward, so a lot can be learned from under 18 April 2019
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze